publication venue for
- Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study. 2023
- Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.. 16. 2022
- Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia. 2022
- Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a).. 15. 2020
- Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.. 14. 2020
- Low-density lipoprotein cholesterol levels among individuals experiencing statin-associated symptoms: Data from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.. 14. 2020
- Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.. 11. 2017
- US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.. 10. 2016
- Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY.. 10. 2015
- Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT.. 10. 2015
- Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.. 9. 2015
- Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.. 9. 2014
- Liver histology during Mipomersen therapy for severe hypercholesterolemia.. 8. 2014
- Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.. 7. 2013
- Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.. 7. 2013
- Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative.. 4. 2010
- PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY.. 3. 2009
- The low-density lipoprotein hypothesis: Proven again with the Improved Reduction of Outcomes: Vytorin Efficacy International Trial.. 9. 2015
- Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. 2018
- Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. 2017